参考文献/References:
[1]Vella MA, Crandall ML, Patel MB. Acute management of traumatic brain injury [J].Surg Clin N Am, 2017, 97(5): 1015-1530.
[2]Zibara K, Ballout N, Mondello S, et al. Combination of drug and stem cells neurotherapy: potential interventions in neurotrauma and traumatic brain injury [J]. Neuropharmacology, 2019, 145(Pt B): 177-198.
[3]Yasar Yildiz S, Kuru P, Toksoy Oner E, et al. Functional stability of plasminogen activator inhibitor-1 [J]. Sci World J, 2014, 2014: 858293.
[4]Chen R, Yan J, Liu P, et al. Plasminogen activator inhibitor links obesity and thrombotic cerebrovascular diseases: the roles of PAI-1 and obesity on stroke [J]. Metab Brain Dis, 2017, 32(3): 667-673.
[5]Sillen M, Declerck PJ. Targeting PAI-1 in cardiovascular disease: structural insights into PAI-1 functionality and inhibition [J]. Front Cardiovasc Med, 2020, 7: 622473.
[6]Placencio VR, DeClerck YA. Plasminogen activator inhibitor-1 in cancer: rationale and insight for future therapeutic testing [J]. Cancer Res, 2015, 75(15): 2969-2974.
[7]Rabieian R, Boshtam M, Zareei M, et al. Plasminogen activator inhibitor type-1 as a regulator of fibrosis [J]. J Cell Biochem, 2018, 119(1): 17-27.
[8]Bae SC, Lee YH. Association between plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and circulating PAI-1 level in systemic lupus erythematosus and rheumatoid arthritis [J]. Z Rheumatol, 2020, 79(3): 312-318.
[9]Agirbasli M, Eren M, Eren F, et al. Enhanced functional stability of plasminogen activator inhibitor-1 in patients with livedoid vasculopathy [J]. J Thromb Thrombolysis, 2011, 32(1): 59-63.
[10]van de Craen B, Declerck PJ, Gils A. The biochemistry, physiology and pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo [J]. Thrombosis Res, 2012, 130(4): 576-585.
[11]Cifarelli V, Beeman SC, Smith GI, et al. Decreased adipose tissue oxygenation associates with insulin resistance in individuals with obesity [J]. J Clin Invest, 2020, 130(12):6688-6699.
[12]Cesaro S, Mauro M, Sattin G, et al. PAI-1 and protein C as early markers of veno-occlusive disease in patients treated for Wilms tumor [J]. Pediat Blood Cancer, 2019, 66(7):e27695.
[13]Rahman FA, Krause MP. PAI-1, the plasminogen system, and skeletal muscle [J]. Int J Mol Sci, 2020, 21(19): 7066.
[14]Krause MP, Al-Sajee D, D'Souza DM, et al. Impaired macrophage and satellite cell infiltration occurs in a muscle-specific fashion following injury in diabetic skeletal muscle [J]. PloS One, 2013, 8(8): e70971.
[15]Vaughan DE, Rai R, Khan SS, et al. Plasminogen activator inhibitor-1 is a marker and a mediator of senescence [J]. Arterioscler Thromb Vasc Biol, 2017, 37(8): 1446-1452.
[16]Gravanis I, Tsirka SE. Tissue plasminogen activator and glial function [J]. Glia, 2005, 49(2): 177-183.
[17]Karin H, Fredrik B, Michael N, et al. Expression of plasminogen activator inhibitor-1 and protease nexin-1 in human astrocytes: response to injury-related factors [J]. J Neurosci Res, 2010, 88(11): 2441-2449.
[18]Shlosberg D, Benifla M, Kaufer D, et al. Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury [J]. Nat Rev Neurol, 2010, 6(7): 393-403.
[19]Maruyama NO, Estrela HF, Sales EBO, et al. The tissue-type plasminogen activator-plasminogen activator inhibitor 1 complex promotes neurovascular injury in brain trauma: evidence from mice and humans [J]. Brain, 2012, 135(Pt 11): 3251-3264.
[20]Schwarzmaier SM, Kim SW, Trabold R, et al. Temporal profile of thrombogenesis in the cerebral microcirculation after traumatic brain injury in mice [J]. J Neurotrauma, 2010, 27(1): 121-130.
[21]Griemert EV, Schwarzmaier SM, Hummel R, et al. PAI-1 augments damage by impairing fibrinolysis after traumatic brain injury [J]. Ann Neurol, 2019, 85(5): 667-680.
[22]Condron M, Rowell S, Dewey E, et al. The procoagulant molecule plasminogen activator inhibitor-1 is associated with injury severity and shock in patients with and without traumatic brain injury [J]. J Trauma Acute Care Surg, 2018, 85(5): 888-893.
[23]Giuliano S, Talarico S, Bruno L, et al. Growth hormone deficiency and hypopituitarism in adults after complicated mild traumatic brain injury [J]. Endocrine, 2017, 58(1):115-123.
[24]Frendl I, Katko M, Galgoczi E, et al. Plasminogen activator inhibitor type 1: a possible novel biomarker of late pituitary dysfunction after mild traumatic brain injury [J]. J Neurotrauma, 2017, 34(23): 3238-3244.
[25]Stein SC, Chen XH, Sinson GP, et al. Intravascular coagulation: a major secondary insult in nonfatal traumatic brain injury [J]. J Neurosurg, 2002, 97(6): 1373-1377.
相似文献/References:
[1]张善纲 综述.现代战争中颅脑损伤的特点及功能康复[J].中国临床神经外科杂志,2015,(11):701.[doi:10.13798/j.issn.1009-153X.2015.11.021]
[2]钟秀均 黄书岚.复方醒脑液治疗颅脑损伤后综合征的临床观察[J].中国临床神经外科杂志,2016,(05):278.[doi:10.13798/j.issn.1009-153X.2016.05.007]
ZHONG Xiu-jun,HUANG Shu-lan..Clinical observation on treatment of compound decoction for cerebral prorection for post-traumatic brain syndrome[J].,2016,(12):278.[doi:10.13798/j.issn.1009-153X.2016.05.007]
[3]李国亮 邸 方 杨亚东.香芹酚通过抑制脑水肿与氧化应激反应保护大鼠
颅脑损伤[J].中国临床神经外科杂志,2016,(05):283.[doi:10.13798/j.issn.1009-153X.2016.05.009]
LI Guo-liang,DI Fang,YANG Ya-dong..Carvacrol protects against traumatic brain injury in rats through suppressing the brain edma and oxidative stress[J].,2016,(12):283.[doi:10.13798/j.issn.1009-153X.2016.05.009]
[4]罗心凯 陈治标 陈谦学.免缝胶原海绵人工硬脑膜在颅脑损伤大骨瓣减压术中的应用[J].中国临床神经外科杂志,2016,(06):357.[doi:10.13798/j.issn.1009-153X.2016.06.012]
LUO Xin-kai,CHEN Zhi-biao,CHEN Qian-xue..Application of collagen sponge artificial dura without suturing to big bone flap decompression after traumatic brain injury[J].,2016,(12):357.[doi:10.13798/j.issn.1009-153X.2016.06.012]
[5]贺瑛福 肖宗宇 马进海 许常林 裴 杰 袁 岗 张广华 巨 虎.高海拔地区重型颅脑损伤血清FSH、LH、PRL的变化[J].中国临床神经外科杂志,2016,(06):359.[doi:10.13798/j.issn.1009-153X.2016.06.013]
HE Ying-fu,XIAO Zong-yu,MA Jin-hai,et al.Changes in serum FSH, LH and PRL levels in the patients with severe traumatic brain injury in plateau[J].,2016,(12):359.[doi:10.13798/j.issn.1009-153X.2016.06.013]
[6]满明昊 李立宏 杨彦龙 李 敏 郭少春.颅脑损伤术后细胞免疫指标变化及脾多肽对其影响[J].中国临床神经外科杂志,2016,(06):362.[doi:10.13798/j.issn.1009-153X.2016.06.014]
MAN Ming-hao,LI Li-hong,YANG Yan-yong,et al.Changes in peripheral cells immunity after operation and effect of spleen polypeptide on them in patients with traumatic brain injury[J].,2016,(12):362.[doi:10.13798/j.issn.1009-153X.2016.06.014]
[7]程 勇 秦加新 戢翰升 李 刚 聂劲林 李 强.颅脑损伤术中急性脑膨出的相关因素分析[J].中国临床神经外科杂志,2016,(06):374.[doi:10.13798/j.issn.1009-153X.2016.06.019]
[8]张一帆 综述 张国来 审校.弥漫性轴索损伤影像学诊断的研究进展[J].中国临床神经外科杂志,2016,(07):442.[doi:10.13798/j.issn.1009-153X.2016.07.020]
[9]陈吉钢 张丹枫 魏嘉良 邹 伟 侯立军.创伤性眶上裂综合征的治疗陈吉钢[J].中国临床神经外科杂志,2016,(04):200.[doi:10.13798/j.issn.1009-153X.2016.04.003]
CHEN Ji-gang,ZHANG Dan-feng,WEI Jiang-liang,et al.Management of traumatic superior orbital fissure syndrome (report of 22 cases)[J].,2016,(12):200.[doi:10.13798/j.issn.1009-153X.2016.04.003]
[10]肖连福 黄瑞宏 陈昌勇.外伤性颅内静脉窦血栓形成1例[J].中国临床神经外科杂志,2016,(04):256.[doi:10.13798/j.issn.1009-153X.2016.04.024]